Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 51.20%
March 31, 2026 48.22%
December 31, 2025 49.58%
September 30, 2025 48.54%
June 30, 2025 48.23%
March 31, 2025 48.41%
December 31, 2024 48.91%
September 30, 2024 46.17%
June 30, 2024 47.49%
March 31, 2024 46.70%
December 31, 2023 41.82%
September 30, 2023 39.84%
June 30, 2023 43.33%
March 31, 2023 42.12%
December 31, 2022 45.09%
September 30, 2022 40.40%
June 30, 2022 41.56%
March 31, 2022 39.62%
December 31, 2021 45.77%
September 30, 2021 45.32%
June 30, 2021 44.49%
March 31, 2021 45.17%
December 31, 2020 37.68%
September 30, 2020 41.20%
June 30, 2020 37.82%
Date Value
March 31, 2020 41.75%
December 31, 2019 42.27%
September 30, 2019 42.86%
June 30, 2019 43.88%
March 31, 2019 43.89%
December 31, 2018 44.79%
September 30, 2018 46.00%
June 30, 2018 44.48%
March 31, 2018 43.29%
December 31, 2017 44.69%
September 30, 2017 44.72%
June 30, 2017 45.08%
March 31, 2017 44.43%
December 31, 2016 44.55%
September 30, 2016 43.20%
June 30, 2016 44.25%
March 31, 2016 43.53%
December 31, 2015 43.57%
September 30, 2015 43.51%
June 30, 2015 44.09%
March 31, 2015 42.74%
December 31, 2014 45.29%
September 30, 2014 44.58%
June 30, 2014 43.16%
March 31, 2014 43.65%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Baxter International, Inc. 33.55%
DexCom, Inc. 63.44%
Abbott Laboratories 52.64%
AngioDynamics, Inc. 50.87%
Alphatec Holdings, Inc. 62.90%